(2) Disinfection byproducts,
maximum residual disinfectant levels and disinfection byproduct precursors and
enhanced coagulation or enhanced softening. This section applies to the
reporting requirements of
R309-210-8,
R309-215-12 and
R309-215-13.
For the reporting requirements of
R309-210-9,
R309-210-10 and
R309-215-15 are contained within
R309-210-9,
R309-210-10 and
R309-215-15,
respectively.
(a) Systems required to sample
quarterly or more frequently shall report to the State within 10 days after the
end of each quarter in which samples were collected. Systems required to sample
less frequently than quarterly shall report to the State within 10 days after
the end of each monitoring period in which samples were collected. The Director
may choose to perform calculations and determine whether the MCL was exceeded,
in lieu of having the system report that information.
(b) Disinfection byproducts. Systems shall
report the information specified.
(i) Systems
monitoring for TTHMs and HAA5 under the requirements of
R309-210-8(2)
on a quarterly or more frequent basis shall report:
(A) The number of samples taken during the
last quarter.
(B) The location,
date, and result of each sample taken during the last quarter.
(C) The arithmetic average of all samples
taken in the last quarter.
(D) The
annual arithmetic average of the quarterly arithmetic averages of this section
for the last four quarters.
(E)
Whether, based on
R309-210-8(6)(b)(i),
the MCL was violated.
(ii) Systems monitoring for TTHMs and HAA5
under the requirements of
R309-210-8(2)
less frequently than quarterly (but at least annually) shall report:
(A) The number of samples taken during the
last year.
(B) The location, date,
and result of each sample taken during the last monitoring period.
(C) The arithmetic average of all samples
taken over the last year.
(D)
Whether, based on
R309-210-8(6)(b)(i),
the MCL was violated.
(iii) Systems monitoring for TTHMs and HAA5
under the requirements of
R309-210-8(2)
less frequently than annually shall report:
(A) The location, date, and result of the
last sample taken.
(B) Whether,
based on
R309-210-8(6)(b)(i),
the MCL was violated.
(iv) Systems monitoring for chlorite under
the requirements of
R309-210-8(2)
shall report:
(A) The number of entry point
samples taken each month for the last 3 months.
(B) The location, date, and result of each
sample (both entry point and distribution system) taken during the last
quarter.
(C) For each month in the
reporting period, the arithmetic average of all samples taken in each three
sample set taken in the distribution system.
(D) Whether, based on
R309-210-8(6)(b)(ii),
the MCL was violated.
(v) System monitoring for bromate under the
requirements of
R309-210-8(2)
shall report:
(A) The number of samples taken
during the last quarter.
(B) The
location, date, and result of each sample taken during the last
quarter.
(C) The arithmetic average
of the monthly arithmetic averages of all samples taken in the last
year.
(D) Whether, based on
R309-210-8(6)(b)(iii),
the MCL was violated.
(c) Disinfectants. Systems shall report the
information specified to the Director within ten days after the end of each
month the system serves water to the public, except as otherwise noted:
(i) Systems monitoring for chlorine or
chloramines under the requirements of
R309-210-8(3)(a)
shall report and certify, by signing the report form provided by the Director,
that all the information provided is accurate and correct and that any chemical
introduced into the drinking water complies with ANSI/NSF Standard 60:
(A) The number of samples taken during each
month of the last quarter.
(B) The
monthly arithmetic average of all samples taken in each month for the last 12
months.
(C) The arithmetic average
of all monthly averages for the last 12 months.
(D) The additional data required in
R309-210-8(3)(a)(ii).
(E) Whether, based on
R309-210-8(6)(c)(i),
the MRDL was violated.
(ii) Systems monitoring for chlorine dioxide
under the requirements of
R309-210-8(3)
shall report:
(A) The dates, results, and
locations of samples taken during the last quarter.
(B) Whether, based on
R309-210-8(6)(c)(ii),
the MRDL was violated.
(C) Whether
the MRDL was exceeded in any two consecutive daily samples and whether the
resulting violation was acute or nonacute.
(d) Disinfection byproduct precursors and
enhanced coagulation or enhanced softening. Systems shall report the
information specified.
(i) Systems monitoring
monthly or quarterly for TOC under the requirements of
R309-215-12 and required to meet the enhanced coagulation or enhanced softening
requirements in
R309-215-13(2)(b)
or (c) shall report:
(A) The number of paired (source water and
treated water) samples taken during the last quarter.
(B) The location, date, and results of each
paired sample and associated alkalinity taken during the last
quarter.
(C) For each month in the
reporting period that paired samples were taken, the arithmetic average of the
percent reduction of TOC for each paired sample and the required TOC percent
removal.
(D) Calculations for
determining compliance with the TOC percent removal requirements, as provided
in
R309-215-13(3)(a).
(E) Whether the system is in compliance with
the enhanced coagulation or enhanced softening percent removal requirements in
R309-215-13(2)
for the last four quarters.
(ii) Systems monitoring monthly or quarterly
for TOC under the requirements of
R309-215-12 and meeting one or more of the alternative compliance criteria in
R309-215-13(1)(b)
or (c) shall report:
(A) The alternative compliance criterion that
the system is using.
(B) The number
of paired samples taken during the last quarter.
(C) The location, date, and result of each
paired sample and associated alkalinity taken during the last
quarter.
(D) The running annual
arithmetic average based on monthly averages (or quarterly samples) of source
water TOC for systems meeting a criterion in
R309-215-13(1)(b)(i)
or (iii) or of treated water TOC for systems
meeting the criterion in
R309-215-13(1)(b)(ii).
(E) The running annual arithmetic average
based on monthly averages (or quarterly samples) of source water SUVA for
systems meeting the criterion in
R309-215-13(1)(b)(v)
or of treated water SUVA for systems meeting the criterion in
R309-215-13(1)(b)(vi).
(F) The running annual average of source
water alkalinity for systems meeting the criterion in
R309-215-13(1)(b)(iii)
and of treated water alkalinity for systems meeting the criterion in
R309-215-13(1)(c)(i).
(G) The running annual average for both TTHM
and HAA5 for systems meeting the criterion in
R309-215-13(1)(b)(iii)
or (iv).
(H) The running annual average of the amount
of magnesium hardness removal (as CaCO3, in mg/L) for
systems meeting the criterion in
R309-215-13(1)(c)(ii).
(I) Whether the system is in compliance with
the particular alternative compliance criterion in
R309-215-13(1)(b)
or (c).